PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Haen, S.P.* ; Eyb, V.* ; Mirza, N.* ; Naumann, A.* ; Peter, A. ; Loeffler, M.W.* ; Faul, C.* ; Vogel, W.* ; Bethge, W.A.* ; Rammensee, H.-G.* ; Kanz, L.* ; Heni, M.

Uric acid as a novel biomarker for bone-marrow function and incipient hematopoietic reconstitution after aplasia in patients with hematologic malignancies.

J. Cancer Res. Clin. Oncol. 143, 759-771 (2017)
Publ. Version/Full Text DOI PMC
Open Access Gold
Prolonged aplasia and graft failure (GF) represent life-threatening complications after hematopoietic cell transplantation (HCT) requiring suitable biomarkers for early detection and differentiation between GF and poor graft function (PGF). Uric acid (UA) is a strong immunological danger signal. Laboratory results were analyzed from patients undergoing either allogeneic or autologous HCT or induction chemotherapy for acute leukemia (n = 50 per group, n = 150 total). During therapy, UA levels declined from normal values to hypouricemic values (all p < 0.001). Alongside hematopoietic recovery, UA serum levels returned to baseline values. During aplasia, UA levels remained low and started steadily increasing (defined as > two consecutive days, median one 2-day increase) at a median of 1 day before rising leukocytes in allogeneic HCT (p = 0.01) and together with leukocytes in autologous HCT (median one 2-day increase). During induction chemotherapy, a UA increase was also observed alongside rising leukocytes/neutrophils but also several times during aplasia (median 3 increases). Most HCT patients had no detectable leukocytes during aplasia, while some leukocytes remained detectable after induction therapy. No increase in UA levels was observed without concomitant or subsequent rise of leukocytes. Changes in UA serum levels can indicate incipient or remaining immunological activity after HCT or induction therapy. They may, therefore, help to differentiate between PGF and GF.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
3.503
1.021
5
8
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Uric Acid ; Allogeneic Hematopoietic Cell Transplantation ; Autologous Stem Cell Transplantation ; Leukemia ; Danger Signal; Stem-cell Transplantation; Renal Tubular Dysfunction; Acute Myeloid-leukemia; Poor Graft Function; Endogenous Adjuvants; Immune-system; Dying Cells; Failure; Danger; Injury
Language english
Publication Year 2017
HGF-reported in Year 2017
ISSN (print) / ISBN 0171-5216
e-ISSN 1432-1335
Journal Journal of Cancer Research and Clinical Oncology
Quellenangaben Volume: 143, Issue: 5, Pages: 759-771 Article Number: , Supplement: ,
Publisher Springer
Publishing Place New York
Reviewing status Peer reviewed
Institute(s) Institute of Diabetes Research and Metabolic Diseases (IDM)
POF-Topic(s) 90000 - German Center for Diabetes Research
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-502400-001
DOI 10.1007/s00432-017-2348-z
WOS ID WOS:000399175600002
PubMed ID 28210842
Scopus ID 85013040571
Erfassungsdatum 2017-06-21
[➜Report correction]